🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Spectral AI director DiMaio buys $10,320 in company stock

Published 05/14/2024, 11:20 AM
MDAI
-

Spectral AI, Inc. (NASDAQ:MDAI), a company specializing in surgical and medical instruments and apparatus, has reported a series of stock transactions by director John Michael DiMaio. According to the latest filings, DiMaio has increased his stake in the company, purchasing shares valued at a total of $10,320.

The transactions, which took place over several dates, saw DiMaio acquiring 6,000 shares at an average price of $1.72 per share. The prices for these purchases ranged from $1.71 to $1.73, as detailed in the footnotes of the filing. This purchase has raised his total direct holdings in Spectral AI to 2,491,908 shares.

In addition to the recent acquisitions, earlier transactions categorized as "L" transactions in the filing, indicated that DiMaio bought another 4,000 shares at prices between $2.20 and $2.69, totaling $9,780. These transactions reflect DiMaio's continued investment in the company and possibly his confidence in its future prospects.

Investors often monitor insider transactions such as these for signals about executive sentiment towards the company's performance and outlook. DiMaio's role as a director and a significant shareholder suggests that his recent stock activities might be of particular interest to current and potential investors.

Spectral AI has not released any statements regarding these transactions, and the purchases follow the standard reporting procedures for insider activities. The company, incorporated in Delaware, continues to operate in the medical device sector, providing innovative solutions within its field.

InvestingPro Insights

As investors consider the recent insider trading activity by director John Michael DiMaio at Spectral AI, Inc. (NASDAQ:MDAI), it is essential to review the company's financial health and market performance for a more comprehensive analysis. Spectral AI's market capitalization stands at approximately $30.24 million, reflecting its size within the surgical and medical instruments sector. Despite a challenging financial performance, with a negative P/E ratio of -1.26 and an adjusted P/E ratio for the last twelve months as of Q1 2024 at -2.29, the company holds more cash than debt on its balance sheet—an InvestingPro Tip that could indicate some financial resilience.

However, the revenue growth presents a mixed picture. Although there was a quarterly revenue growth of 24.58% in Q1 2024, the revenue for the last twelve months as of Q1 2024 shows a decline of -21.53%. This juxtaposition of short-term growth against a longer-term decline could be critical for investors assessing the company's trajectory.

Another InvestingPro Tip to consider is the stock's recent performance, which has fared poorly, with a one-month price total return of -17.0%. This could reflect market sentiment and align with the concerns raised by analysts who do not anticipate the company will be profitable this year. Additionally, Spectral AI does not pay a dividend, which might influence investment decisions for those seeking income-generating stocks.

For investors intrigued by the recent insider transactions and considering a deeper dive into Spectral AI's financials, there are 6 additional InvestingPro Tips available at https://www.investing.com/pro/MDAI. To enhance your research, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, providing further insights that could help in making a more informed investment decision.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.